Literature DB >> 159649

Pulmonary hypertension complicating portal hypertension.

D Lebrec, J P Capron, D Dhumeaux, J P Benhamou.   

Abstract

We report 9 patients with pulmonary hypertension complicating portal hypertension. The cause of portal hypertension was cirrhosis in 7 patients, nodular regenerative hyperplasia of the liver in 1, and portal vein obstruction in 1. Six patients had been treated by portal-systemic shunting before the clinical onset of pulmonary hypertension. The interval between the first manifestation of portal hypertension and the recognition of pulmonary hypertension ranged from 2 to 15 years. Histologic examination in 1 of these patients revealed medial hypertrophy, concentric intimal proliferation, and plexiform lesions affecting the small pulmonary arteries. Pulmonary hypertension might result from the effect of a vasoconstrictive agent on the small pulmonary arteries or of a substance toxic to the walls of these vessels that is produced in the splanchnic territory, destroyed by the liver in normal subjects, and reaches the pulmonary arteries through portal-systemic shunts in these patients.

Entities:  

Mesh:

Year:  1979        PMID: 159649     DOI: 10.1164/arrd.1979.120.4.849

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  19 in total

1.  Esophageal variceal ligation for esophageal variceal hemorrhage in a patient with portal and primary pulmonary hypertension complicating myelofibrosis.

Authors:  W C Lee; H C Lin; S H Tsay; Y Y Yang; M C Hou; F Y Lee; F Y Chang; S D Lee
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

2.  Portopulmonary hypertension: challenges in diagnosis and management.

Authors:  Patrick J Troy; Aaron B Waxman
Journal:  Therap Adv Gastroenterol       Date:  2009-09       Impact factor: 4.409

Review 3.  Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.

Authors:  Marek Hartleb; Krzysztof Gutkowski; Piotr Milkiewicz
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

Review 4.  Appetite suppressants and pulmonary hypertension.

Authors:  N F Voelkel
Journal:  Thorax       Date:  1997-08       Impact factor: 9.139

5.  Severe pulmonary hypertension and multiple left coronary arterial fistulas in association with congenital hepatic fibrosis.

Authors:  N G Dewhurst; N R Colledge; H C Miller
Journal:  Br Heart J       Date:  1987-11

Review 6.  Pulmonary hypertension.

Authors:  J R Michael; W R Summer
Journal:  Lung       Date:  1985       Impact factor: 2.584

7.  Severe pulmonary artery hypertension.

Authors:  A Roglan; A Artigas; J Solé
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

Review 8.  Hepatopulmonary Syndrome and Portopulmonary Hypertension: The Pulmonary Vascular Enigmas of Liver Disease.

Authors:  Michael J Krowka
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-02

9.  Pulmonary Hypertension in a Patient With Congenital Heart Defects and Heterotaxy Syndrome.

Authors:  Tariq Yousuf; Jason Kramer; Brody Jones; Hesam Keshmiri; Muhyaldeen Dia
Journal:  Ochsner J       Date:  2016

10.  Pulmonary hypertension associated with primary biliary cirrhosis in the absence of portal hypertension: a case report.

Authors:  E M Yoshida; S R Erb; D N Ostrow; D R Ricci; C H Scudamore; G Fradet
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.